107 related articles for article (PubMed ID: 30935694)
1. UNC93B1 promotes tumoral growth by controlling the secretion level of granulocyte macrophage colony-stimulating factor in human oral cancer.
Wagai S; Kasamatsu A; Iyoda M; Hayashi F; Hiroshima K; Yoshimura S; Miyamoto I; Nakashima D; Endo-Sakamoto Y; Shiiba M; Tanzawa H; Uzawa K
Biochem Biophys Res Commun; 2019 May; 513(1):81-87. PubMed ID: 30935694
[TBL] [Abstract][Full Text] [Related]
2. Semaphorin7A Promotion of Tumoral Growth and Metastasis in Human Oral Cancer by Regulation of G1 Cell Cycle and Matrix Metalloproteases: Possible Contribution to Tumoral Angiogenesis.
Saito T; Kasamatsu A; Ogawara K; Miyamoto I; Saito K; Iyoda M; Suzuki T; Endo-Sakamoto Y; Shiiba M; Tanzawa H; Uzawa K
PLoS One; 2015; 10(9):e0137923. PubMed ID: 26378920
[TBL] [Abstract][Full Text] [Related]
3. TEAD4-YAP interaction regulates tumoral growth by controlling cell-cycle arrest at the G1 phase.
Takeuchi S; Kasamatsu A; Yamatoji M; Nakashima D; Endo-Sakamoto Y; Koide N; Takahara T; Shimizu T; Iyoda M; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
Biochem Biophys Res Commun; 2017 Apr; 486(2):385-390. PubMed ID: 28315328
[TBL] [Abstract][Full Text] [Related]
4. Cavin-2 in oral cancer: A potential predictor for tumor progression.
Unozawa M; Kasamatsu A; Higo M; Fukumoto C; Koyama T; Sakazume T; Nakashima D; Ogawara K; Yokoe H; Shiiba M; Tanzawa H; Uzawa K
Mol Carcinog; 2016 Jun; 55(6):1037-47. PubMed ID: 26086332
[TBL] [Abstract][Full Text] [Related]
5. Epithelial cell transforming sequence 2 in human oral cancer.
Iyoda M; Kasamatsu A; Ishigami T; Nakashima D; Endo-Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
PLoS One; 2010 Nov; 5(11):e14082. PubMed ID: 21124766
[TBL] [Abstract][Full Text] [Related]
6. UBE2S associated with OSCC proliferation by promotion of P21 degradation via the ubiquitin-proteasome system.
Yoshimura S; Kasamatsu A; Nakashima D; Iyoda M; Kasama H; Saito T; Takahara T; Endo-Sakamoto Y; Shiiba M; Tanzawa H; Uzawa K
Biochem Biophys Res Commun; 2017 Apr; 485(4):820-825. PubMed ID: 28257844
[TBL] [Abstract][Full Text] [Related]
7. Kinesin family member 4A: a potential predictor for progression of human oral cancer.
Minakawa Y; Kasamatsu A; Koike H; Higo M; Nakashima D; Kouzu Y; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
PLoS One; 2013; 8(12):e85951. PubMed ID: 24386490
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of tripartite motif (TRIM) like 2 promotes tumoral growth in human oral cancer.
Hayashi F; Kasamatsu A; Endo-Sakamoto Y; Eizuka K; Hiroshima K; Kita A; Saito T; Koike K; Tanzawa H; Uzawa K
Biochem Biophys Res Commun; 2019 Jan; 508(4):1133-1138. PubMed ID: 30554657
[TBL] [Abstract][Full Text] [Related]
9. Annexin A10 in human oral cancer: biomarker for tumoral growth via G1/S transition by targeting MAPK signaling pathways.
Shimizu T; Kasamatsu A; Yamamoto A; Koike K; Ishige S; Takatori H; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
PLoS One; 2012; 7(9):e45510. PubMed ID: 23029062
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of CDCA2 in human squamous cell carcinoma: correlation with prevention of G1 phase arrest and apoptosis.
Uchida F; Uzawa K; Kasamatsu A; Takatori H; Sakamoto Y; Ogawara K; Shiiba M; Bukawa H; Tanzawa H
PLoS One; 2013; 8(2):e56381. PubMed ID: 23418564
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
[TBL] [Abstract][Full Text] [Related]
12. Persephin: A potential key component in human oral cancer progression through the RET receptor tyrosine kinase-mitogen-activated protein kinase signaling pathway.
Baba T; Sakamoto Y; Kasamatsu A; Minakawa Y; Yokota S; Higo M; Yokoe H; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
Mol Carcinog; 2015 Aug; 54(8):608-17. PubMed ID: 24375483
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidylcholine acyltransferase1 overexpression promotes oral squamous cell carcinoma progression via enhanced biosynthesis of platelet-activating factor.
Shida-Sakazume T; Endo-Sakamoto Y; Unozawa M; Fukumoto C; Shimada K; Kasamatsu A; Ogawara K; Yokoe H; Shiiba M; Tanzawa H; Uzawa K
PLoS One; 2015; 10(3):e0120143. PubMed ID: 25803864
[TBL] [Abstract][Full Text] [Related]
14. Adenosine A2b receptor promotes progression of human oral cancer.
Kasama H; Sakamoto Y; Kasamatsu A; Okamoto A; Koyama T; Minakawa Y; Ogawara K; Yokoe H; Shiiba M; Tanzawa H; Uzawa K
BMC Cancer; 2015 Jul; 15():563. PubMed ID: 26228921
[TBL] [Abstract][Full Text] [Related]
15. ANGPTL3 is a novel biomarker as it activates ERK/MAPK pathway in oral cancer.
Koyama T; Ogawara K; Kasamatsu A; Okamoto A; Kasama H; Minakawa Y; Shimada K; Yokoe H; Shiiba M; Tanzawa H; Uzawa K
Cancer Med; 2015 May; 4(5):759-69. PubMed ID: 25644496
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte-macrophage colony-stimulating factor abrogates transforming growth factor-beta 1-mediated cell cycle arrest by up-regulating cyclin D2/Cdk6.
Ohtsuki F; Yamamoto M; Nakagawa T; Tanizawa T; Wada H
Br J Haematol; 1997 Sep; 98(3):520-7. PubMed ID: 9332304
[TBL] [Abstract][Full Text] [Related]
17. Novel mechanism of aberrant ZIP4 expression with zinc supplementation in oral tumorigenesis.
Ishida S; Kasamatsu A; Endo-Sakamoto Y; Nakashima D; Koide N; Takahara T; Shimizu T; Iyoda M; Shiiba M; Tanzawa H; Uzawa K
Biochem Biophys Res Commun; 2017 Jan; 483(1):339-345. PubMed ID: 28017725
[TBL] [Abstract][Full Text] [Related]
18. miR-433 inhibits oral squamous cell carcinoma (OSCC) cell growth and metastasis by targeting HDAC6.
Wang XC; Ma Y; Meng PS; Han JL; Yu HY; Bi LJ
Oral Oncol; 2015 Jul; 51(7):674-82. PubMed ID: 25962939
[TBL] [Abstract][Full Text] [Related]
19. Critical role of deoxynucleotidyl transferase terminal interacting protein 1 in oral cancer.
Sawai Y; Kasamatsu A; Nakashima D; Fushimi K; Kasama H; Iyoda M; Kouzu Y; Shiiba M; Tanzawa H; Uzawa K
Lab Invest; 2018 Aug; 98(8):980-988. PubMed ID: 29855544
[TBL] [Abstract][Full Text] [Related]
20. IFITM3 knockdown reduces the expression of CCND1 and CDK4 and suppresses the growth of oral squamous cell carcinoma cells.
Gan CP; Sam KK; Yee PS; Zainal NS; Lee BKB; Abdul Rahman ZA; Patel V; Tan AC; Zain RB; Cheong SC
Cell Oncol (Dordr); 2019 Aug; 42(4):477-490. PubMed ID: 30949979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]